336 related articles for article (PubMed ID: 32536771)
1. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.
Kovac JD; Milovanovic T; Dugalic V; Dumic I
World J Gastroenterol; 2020 May; 26(17):2012-2029. PubMed ID: 32536771
[TBL] [Abstract][Full Text] [Related]
2. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.
Kovac JD; Ivanovic A; Milovanovic T; Micev M; Alessandrino F; Gore RM
Radiol Oncol; 2021 Jan; 55(2):130-143. PubMed ID: 33544992
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
[TBL] [Abstract][Full Text] [Related]
4. Combined hepatocellular and cholangiocellular carcinoma.
Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H
Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042
[TBL] [Abstract][Full Text] [Related]
5. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
6. MR imaging in cirrhosis and hepatocellular carcinoma.
Barr DC; Hussain HK
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
[TBL] [Abstract][Full Text] [Related]
7. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
8. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
Kim MJ; Lee S; An C
Eur Radiol; 2019 Sep; 29(9):5101-5110. PubMed ID: 30788586
[TBL] [Abstract][Full Text] [Related]
9. Fibrolamellar hepatocellular carcinoma: pitfalls in nonoperative diagnosis.
Titelbaum DS; Burke DR; Meranze SG; Saul SH
Radiology; 1988 Apr; 167(1):25-30. PubMed ID: 2831564
[TBL] [Abstract][Full Text] [Related]
10. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Jeon TY; Kim SH; Lee WJ; Lim HK
Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
Piscaglia F; Iavarone M; Galassi M; Vavassori S; Renzulli M; Forzenigo LV; Granito A; Salvatore V; Sangiovanni A; Golfieri R; Colombo M; Bolondi L
Dig Dis; 2015 Oct; 33(6):735-44. PubMed ID: 26488875
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
13. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
[TBL] [Abstract][Full Text] [Related]
15. Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features.
Liao TC; Liu CA; Chiu NC; Yeh YC; Chiou YY
World J Gastroenterol; 2015 Apr; 21(13):4089-95. PubMed ID: 25852298
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
Viganò L; Lleo A; Muglia R; Gennaro N; Samà L; Colapietro F; Roncalli M; Aghemo A; Chiti A; Di Tommaso L; Solbiati L; Colombo M; Torzilli G
Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
[TBL] [Abstract][Full Text] [Related]
17. Imaging findings of mimickers of hepatocellular carcinoma.
Kim TK; Lee E; Jang HJ
Clin Mol Hepatol; 2015 Dec; 21(4):326-43. PubMed ID: 26770920
[TBL] [Abstract][Full Text] [Related]
18. Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.
Shao H; Cheng W; Yu L; Li Y; Jing H
Hepatogastroenterology; 2015 Jun; 62(140):978-81. PubMed ID: 26902040
[TBL] [Abstract][Full Text] [Related]
19. [Indications for liver biopsy in liver tumors].
Stölzel U; Tannapfel A; Wittekind C; Hamm B; Schuppan D
Dtsch Med Wochenschr; 2000 Sep; 125(36):1041-4. PubMed ID: 11022600
[No Abstract] [Full Text] [Related]
20. Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings.
Liu QY; Huang SQ; Chen JY; Li HG; Gao M; Liu C; Liang BL
Abdom Imaging; 2010 Oct; 35(5):537-42. PubMed ID: 19763681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
